StockData
Arvinas, Inc. logo

Arvinas, Inc. (ARVN) stock

ARVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30
$6.76−0.06 (-0.81%)

Close on Nov 18, 2026Market cap $442.34MP/E 42.3Yield –

Arvinas gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Arvinas

Arvinas has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Arvinas figures

See a number that looks wrong?